Abstract:Abstract Prostate cancer (PCa) is the most frequently diagnosed non-cutaneous malignancy, and the third leading cause of cancer death in males in the United States. The development of the disease is reliant on the activity of the androgen receptor (AR), which promotes proliferation and is required for cell growth and survival. Deregulation of AR leads to the progression of PCa to the incurable form of disease termed castration-resistant prostate cancer (CRPC). One of the underlying mechanisms of AR deregulation is the loss of function of the retinoblastoma (RB) tumor suppressor protein. RB loss is almost exclusively seen in CRPC and is sufficient to induce a CRPC phenotype in primary PCa models. However, RB function is only lost in roughly 30% of tumors. The remaining 70% of tumors that progress to CRPC do so via other mechanisms and retain RB function. A subset of RB positive CRPC tumors progress to lose RB function even in this post-CRPC transition stage of disease. Biological assessment performed in isogenic RB knockdown, both hormone-sensitive and CRPC models, identified distinct functional consequences of RB loss depending on disease state. Transcriptome analysis identified opposing regulated gene signatures between disease stages. Further investigation of the E2F1 cistrome revealed differential E2F1 binding with RB loss in hormone sensitive and CRPC models, identifying distinct roles of E2F1, in the absence of RB, in different disease states. Data to be discussed reveal the stage-specific molecular pathways driven by E2F1 upon RB loss with the potential to promote disease progression. Citation Format: Amy C. Mandigo, Christopher McNair, Kexin Xu, Fugen Li, Matthew J. Schiewer, Myles Brown, Karen E. Knudsen. Stage specific re-calibration of E2F1 function after RB loss [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr LB-087. doi:10.1158/1538-7445.AM2017-LB-087

Cell Anchorage Regulates Apoptosis Through the Retinoblastoma Tumor Suppressor/e2f Pathway.

DAB2IP Coordinates Both PI3K-Akt and ASK1 Pathways for Cell Survival and Apoptosis

Role of Phosphatidylinositol 3-Kinase and Specific Protein Kinase B Isoforms in the Suppression of Apoptosis Mediated by the Abelson Protein-tyrosine Kinase

Cell Detachment Activates the Hippo Pathway Via Cytoskeleton Reorganization to Induce Anoikis

The Rho GTPase RhoB regulates cadherin expression and epithelial cell-cell interaction

MCL1 binding to the reverse BH3 motif of P18INK4C couples cell survival to cell proliferation

TACE-Mediated Ectodomain Shedding of the Type I TGF-b Receptor Downregulates TGF-b Signaling

Epidermal Growth Factor Induces Cell Cycle Arrest and Apoptosis of Squamous Carcinoma Cells Through Reduction of Cell Adhesion

Dephosphorylation of the Retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb

Cell Adhesion Regulates Expression of the Androgen Receptor and Coregulators in Different Prostate Cancer Cells

Retinoblastoma Suppressor Associated Protein 46 (rbap46) Attenuates the Beta-Catenin/tcf Signaling Through Up-Regulation of GSK-3beta Expression.

Human MCF10A Mammary Epithelial Cells Undergo Apoptosis following Actin Depolymerization That Is Independent of Attachment and Rescued by Bcl-2

pRb Inactivation in Mammary Cells Reveals Common Mechanisms for Tumor Initiation and Progression in Divergent Epithelia

Cell Attachment to the Extracellular Matrix Induces Proteasomal Degradation of P21(Cip1) Via Cdc42/Rac1 Signaling

Regulation of cell death by the Abl tyrosine kinase

The G1/S transition is promoted by Rb degradation via the E3 ligase UBR5

Cell aggregation induces phosphorylation of PECAM-1 and Pyk2 and promotes tumor cell anchorage-independent growth

Differential Impact of RB Status on E2F1 Reprogramming in Human Cancer

HDAC Inhibition Impedes Epithelial–mesenchymal Plasticity and Suppresses Metastatic, Castration-Resistant Prostate Cancer

Abstract LB-087: Stage Specific Re-Calibration of E2F1 Function after RB Loss

Cell Adhesion Induces P27kip1-Associated Cell-Cycle Arrest Through Down-Regulation of the SCFSkp2 Ubiquitin Ligase Pathway in Mantle-Cell and Other Non-Hodgkin B-cell Lymphomas